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Scottish Melanoma Group (SMG) data on 2790 melanoma (MM) cases in South East Scotland over a 24-year time period were
analysed in four periods each of 6 years duration grouped into frequently exposed, intermittently exposed, and always covered sites.
Incidence increased significantly over time with females having a higher incidence rate than males. In both sexes, the proportion of
cases seen on the posterior trunk and arm increased significantly (Po0.001), but declines were seen in the proportion of leg tumours
in males (P¼0.09) and of head tumours in females (P¼0.011). Although the proportion of cases decreased for certain sites, the
actual MM incidence increased at all sites. A significant increase in incidence occurred at usually and always covered sites (Po0.001
and Po0.001, respectively) in females and at usually covered sites in males (Po0.001).
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The increase in incidence of primary cutaneous malignant
melanoma (MM) in Caucasian populations worldwide over the
past two decades is well documented. Differences are emerging in
the patterns of change in incidence rates seen between countries.
In ‘high incidence regions’ such as Australia (Green et al, 1993;
Marrett et al, 2001), the annual age-standardised incidence rates
for MM have always been higher in men than in women and the
rate of increase in incidence has been steeper in men over the past
25 years. In more moderate risk areas such as Canada (Bulliard
et al, 1999) and the USA (Chen et al, 1994), the rate of increase in
the incidence of invasive melanomas in males has been so much
greater than that seen in females that male incidence rates have
overtaken those in women. Scotland is a relatively ‘low incidence
region’, with actual incidence rates of 8–10 per 100000 population
in 1998 compared with 30–45 per 100000 population in New
South Wales in 1995 (Marrett et al, 2001). Incidence rates in
Scotland for MM have always been, and remain, higher in women.
Over the last 25 years, however, the rate of increase has been much
greater for men in Scotland too.
Melanoma incidence in Australasia started to level off in those
born after 1945–1950 (Bulliard and Cox, 2000; Marrett et al, 2001)
with a plateau since the late 1980s, and a similar effect has also
been reported from Canada for those born after 1944 (Bulliard
et al, 1999). No birth cohort effect is yet seen in Scottish data where
incidence continues to rise in men, although there is some levelling
of incidence rates in younger women since 1994 (Mackie et al,
2002).
We have examined the site distribution of invasive MM in South
East (SE) Scotland over a 24-year period (1979–2002) with the
hope of improving our knowledge of the effect of sun exposure
patterns on these cancers.
MATERIALS AND METHODS
Data from the multi-disciplinary Scottish Melanoma Group (SMG),
set up in 1978 to gather detailed clinical, pathological, treatment
and follow-up information in all cases of primary invasive
cutaneous melanoma in Scotland, were used to identify all
National Health Service and private sector patients with invasive
MM (Clark level 2 or deeper) in the years 1979–2002. Registrations
are crosschecked with pathology departments and annually with
the Scottish Cancer Registry with follow-up information at 5, 10, 15
and 20 years after diagnosis. The SMG covering a relatively stable
population of five million is one of very few population-based
melanoma databases in the world.
We have analysed the details of all 2790 patients presenting with
invasive MM in SE Scotland SMG database (population 1.2
million) over a 24-year time period from 1979 to 2002, in four
equal periods each of 6 years. For historical reasons, data from the
Highlands and Western Isles were included, although for
simplicity, we still refer to the study region as SE Scotland.
The sites of the MM were grouped into frequently exposed (face,
scalp, neck, ears, dorsal foot, lip, lower arm, dorsal hand and lower
leg females), usually covered/intermittently exposed (trunk above
waist, upper arm, upper leg, lower leg males) and always covered
(trunk below waist, subungual hand, subungual toe, palm, sole and
mucosal) sites. Unknown sites, tumours on the arm (area
unspecified) and the leg (area unspecified) for males were excluded
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lower leg was classified as ‘frequently exposed’ and male lower leg
as ‘usually covered’; all female data were complete and specified
upper/lower leg and hence no females required exclusion from the
analysis.
The following characteristics were recorded for all patients:
(i) sex, numbers and proportions of male and female,
(ii) age (o50, 50–69, X70),
(iii) site (as above),
(iv) tumour thickness (Breslow 40–0.74, 0.75–1.49, 1.5–3.49,
X3.5mm, Clarks level 2–5 and unknown).
These features were compared across the four periods.
Differences in proportions were tested using the w
2 statistic.
Changes in incidence rates over time were assessed using Poisson
regression. Population estimates for SE Scotland (including
Highland, Lothian, Fife, Borders and Western Isles Health Boards)
from the General Registrars Office for Scotland (GROS) were used
to calculate age-standardised incidence rates (standardised to the
European population).
RESULTS
Overall incidence rates
Over the 24 years (1979–2002), 1759 MM patients (63%) were
female and 1031 (37%) male. The number of cases has increased
significantly over time from 357 cases in the first period to 976 in
the final period, 1997–2002 (Figure 1). The higher incidence in
females persisted throughout the study period, rates increasing in
both sexes similarly (Figure 1).
Sites of occurrence
Overall, the most common sites were the posterior trunk and head
for males and the leg and arm for females (Figures 2A and B); less
common sites were grouped together as ‘other and unknown’ and
of the total 2790 lesions, only 16 (0.57%) were classified as
unknown. For both males and females, the proportion of cases
seen on the posterior trunk and arm increased significantly
(Po0.001) over the study period; no change in proportion was
seen for the anterior trunk. In males, a nonsignificant decline in
the proportion of leg tumours was seen (P¼0.09), and of head
tumours in females (P¼0.011). The proportion of other and
unknown sites decreased in both sexes over time (Table 1a and b).
Although the proportions declined at certain sites, the actual
incidence (number) of melanoma increased at all sites over the
time period, and significantly so with the exception of other and
unknown sites for males and head sites for females (Figures 2A
and B).
Exposure patterns
One thousand two hundred and ninety-six cases were at frequently
exposed sites, 1125 at usually covered sites and 317 at always
covered sites. A significant increase in incidence over time was
seen in females at usually and always covered sites (Po0.001 and
Po0.001, respectively). A similar increase at usually covered sites
was seen in males (Po0.001), with no change at always covered
sites for males (Figures 3A and B).
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Figure 1 Age-standardised incidence rates of melanoma in SE Scotland,
1979–2002.
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Figure 2 Age standardised (European) incidence of melanoma in SE
Scotland at different sites, 1979–2002. (A) Males and (B) Females.
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There was no evidence of a significant deviation in the pattern of
incidence over time by age group; the trend across all sites for all
age groups was of an increase in incidence rates. The only
exception was anterior chest lesions in women where incidence
decreased over time for those greater than 70 years old but
increased for younger age groups (data not shown).
Tumour thickness and histology
A significant decrease in Breslow thickness was seen over the 24-
year time period (Table 2), for each site except the head and neck.
In the first time period, the proportion of thin melanomas was 41%
(Breslow o1.49mm) with an increase to 67% by the fourth time
period. In the first time period, the distribution of histological
types was superficial spreading (49%), nodular (25%) and lentigo
maligna (15%). The same three types were also most frequent in
the fourth time period with distribution markedly changed to
superficial spreading (70%), nodular (10%) and lentigo maligna
(12%).
DISCUSSION
A number of different studies worldwide have analysed site-
specific changes of MM in large populations over extended time
periods. In contrast to trends in overall incidence rates, the
patterns of change in the site distribution of MM seem in general
to be similar between higher and lower incidence regions. Overall,
the commonest sites in males are the trunk (Gallagher et al, 1990;
Thorn et al, 1990; Chen et al, 1994; Bulliard et al, 1999; Bulliard,
2000; Bulliard and Cox, 2000; Marrett et al, 2001; Swerdlow, 2001;
MacKie et al, 2002; Stang et al, 2006) followed by the head and
neck (Chen et al, 1994; Bulliard, 2000; MacKie et al, 2002). In
females, the commonest site for invasive MM is the lower limb
(Gallagher et al, 1990; Thorn et al, 1990; Chen et al, 1994; Bulliard,
2000; Bulliard and Cox, 2000; Marrett et al, 2001; MacKie et al,
2002; Stang et al, 2006). Some studies also suggest a fall in the
incidence of lower limb lesions in males (Chen et al, 1994; Bulliard
et al, 1999) and head and neck lesions in females (Gallagher et al,
1990; Thorn et al, 1990; Green et al, 1993; Chen et al, 1994; Bulliard
et al, 1999; Bulliard and Cox, 2000).
SE Scotland follows the world trends with an increase in the
incidence of invasive MM in both sexes during the past 24 years. A
number of reasons for this increase have been postulated, such as
changes in diagnostic histopathologic criteria, improved case
Table 1 Distribution of tumour site by year and sex (N and %), (a) males
and (b) females
1979–1984 1985–1990 1991–1996 1997–2002 Total
(a) Males
Head 31 62 66 96 255
25.83 25.31 22.92 25.40 24.73
Anterior trunk 16 31 37 49 133
13.33 12.65 12.85 12.96 12.90
Posterior trunk 29 64 92 123 308
24.17 26.12 31.94 32.54 29.87
Arm 7 20 34 40 101
5.83 8.16 11.81 10.58 9.80
Leg 23 36 33 49 141
19.17 14.69 11.46 12.96 13.68
Other and unknown 14 32 26 21 93
11.67 13.06 9.03 5.56 9.02
Total (N) 120 245 288 378 1031
% 100.00 100.00 100.00 100.00 100.00
(b) Females
Head 49 70 95 79 293
21 16 20 13 17
Anterior trunk 17 26 37 41 121
7687 7
Posterior trunk 21 51 50 93 215
91 21 01 6 1 2
Arm 26 54 74 102 256
11 12 15 17 15
Leg 91 184 181 221 677
38 42 37 37 38
Other and unknown 33 53 49 62 197
14 12 10 10 11
Total (N) 237 438 486 598 1759
% 100 100 100 100 100
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Figure 3 Age standardised (European) incidence of melanoma in SE
Scotland at frequently exposed, usually covered and always covered sites,
1979–2002. (A) Males and (B) Females.
Table 2 Breslow group by year (Po0.001)
Breslow
(mm) 1979–1984 1985–1990 1991–1996 1997–2002 Total
40–0.74 96 264 298 427 1085
27 39 39 44 39
0.75–1.49 49 126 143 222 540
14 18 18 23 19
1.5–3.49 96 155 177 171 599
27 23 23 18 21
3.5+ 112 119 137 151 519
31 17 18 15 19
Unknown 4 19 19 5 47
1321 2
Total (N) 357 683 774 976 2790
(%) 100 100 100 100 100
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increase in presentation. Although such factors no doubt account
for some of the increase observed, evidence would suggest that
they do not make a great contribution (van der Esch et al, 1991;
Swerdlow, 2001). Some countries are reporting stabilisation of
incidence rate rises either generally or in younger female patients.
It has been suggested that this may be due to primary prevention
campaigns (Chen et al, 1994; Gaudette and Gao, 1998; Bulliard
et al, 1999; Bulliard and Cox, 2000; Marrett et al, 2001), although
some would argue that it is too early to be seeing falls in melanoma
incidence as a result of such education (Bulliard and Cox, 2000).
Likewise, any fall could reflect increased sunscreen use, which has
become commonplace in the past 25 years. In the late 1970s to
early 1980s, the UVB protection offered by most commercially
available sunscreens was low (SPF 4–10), with little in the way of
available UVA filters. Only in the past 10 years have high-
protection sunscreens (SPF 15–60) become more widely available,
but the levelling off in MM incidence in Scotland has not been seen
elsewhere.
We have reported on changes in site from a lower incidence
temperate area, where intermittent bursts of sun exposure
sometimes with high intensity is the norm, this behaviour having
increased over the past 15 years (Swerdlow, 2001). The site trends
that we observed are similar to those seen worldwide, with a
proportional increase in lesions on the posterior trunk and arms
for both sexes, a proportional decrease in leg lesions in males and
of head and neck lesions in females. In addition to an increase in
intermittent exposure, clothing changes such as the wearing of
briefer clothing during recreational exposure may also have an
effect.
The potential contribution made by different exposure patterns
is further highlighted by our data on changes at ‘frequently
exposed’ compared to ‘usually covered’ sites. A significant increase
was seen in the proportion of MM at ‘usually covered’ sites in
women, with a similar but nonsignificant change in men. This
increase in MM incidence over time may in part be due to an
increase in intermittent sun exposure, as reported from a
comprehensive meta-analysis of all MM studies (Gandini et al,
2005).
In our analysis, we did not adjust for body surface area. It is
reassuring, therefore, that the findings in comparable studies that
did so are similar to ours (Green et al, 1993; Bulliard, 2000; Stang
et al, 2006).
The SMG data set is well known for being more comprehensive
than data available from general cancer registration. It has
certainly allowed us to build a detailed picture of the changes in
site distribution of invasive malignant melanoma in SE Scotland
over time. As it was retrospective, it was not possible to assess skin
type or past sun exposure details for the patients. On a day-to-day
basis, Scotland is certainly a ‘low-exposure’ region for occupa-
tional and recreational purposes. However, intermittent exposure
in the form of regular holidays in the sun has become increasingly
common over the last 20–30 years. The change in site distribution
that we have noted, with more melanomas arising on intermit-
tently exposed skin, may be a reflection of changing lifestyles and
fashion in the last few decades.
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